Health

Results: 2953-2964 of 9264

Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status

PR Newswire associated0

3-minute EEG Test Reliably Detects Memory Impairment, Enabling Earlier Alzheimer's Diagnosis

PR Newswire associated0

SprintRay Acquires EnvisionTEC Dental Product Portfolio, Expanding Commitment to 3D Printing in Dentistry

PR Newswire associated0

Quasar Medical Strengthens Global CDMO Platform with Acquisition of Nordson Medical's Galway and Tecate Facilities

ACCESS Newswire logo

Florence Announces AI-Assisted Workflows to Transform Clinical Trials

PR Newswire associated0

Smartkem Engages Anthony Amato to Support Specific Strategic Initiatives

Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth

PR Newswire associated0

Seegene and Springer Nature Open Applications for 2025-2026 Nature Awards MDx Impact Grants

Business Wire logo

Silence Therapeutics to Participate in September Investor Conferences

The SeqOne team.

SeqOne Acquires Congenica to Create a Global Leader in AI-Powered Genomic Medicine

EQT Life Sciences Leads USD 44 Million Series B Financing in Cyted Health to Accelerate US Expansion

Business Wire logo

Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars